What makes cancer gene therapy so groundbreaking?
Following a recent panel recommendation, the Food and Drug Administration is likely to approve the first-ever gene-altering cancer treatment. What does this mean for patients and for the field of drug development? Mansoor Amiji, University Distinguished Professor of Pharmaceutical Sciences, weighs in.
